• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX®RX; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX®RX; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number CX*RX25RW
Medical Device Problem Code Gas Output Problem (1266)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/17/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
D6a: implanted date: device was not implanted d6b: explanted date: device was not explanted the actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(6).
 
Event or Problem Description
The user facility reported poor oxygenation during a cardiopulmonary bypass (cpb) procedure.Po2 50 mmhg, blood flow rate 5l/min, gas flow rate 2.5l/min, fio2 75%.Became normal after the oxygenator was replaced with a new rx25.No patient harm was reported.The procedure outcome was not reported.The event occurred intra-operative.
 
Additional Manufacturer Narrative
This report is being sent as follow-up no.1 to update section d9, and to provide the completed investigation results.The manufacturing record and the shipping inspection record of the actual product found no anomaly.No other similar report of the product with the involved product code/lot number was found.Based on the investigation result, no anomaly was found in the manufacturing record of the actual sample.Considering the provided information that the blood flow rate was 5 l/min, gas flow rate was 2.5 l/min, and f io2 was 75 %, the following possibilities were inferred as the cause of this incident, but we were unable to confirm the actual product and could not determine the cause.The gas flow rate was low compared to the blood flow rate.Since fio2 was not 100%, oxygen supply quantity was insufficient.Relevant instructions for use (ifu) reference: "measure blood gases and make necessary adjustments as follows.A.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.-to decrease pao2, decrease fio2.-to increase pao2, increase fio2.B.Control paco2 by changing the total gas flow.-to decrease paco2, increase total gas flow.-to increase paco2, decrease total gas flow." "upon patient rewarming, adjust o2 concentration, gas flow rate and blood flow rate by increasing them as needed based on an increasing in patients metabolism.Failure to adjust the gas supply and the blood flow rate appropriately may cause insufficient o2 supply needed or the amount of the patient's gaseous metabolism." "a phenomenon called wet lung may occur when water condensation occurs inside fibers of microporous membrane oxygenators with blood flowing exterior to the fibers.This may occur when oxygenators are used for a longer period of time.If water condensation and/or a decrease in pao2 and/or an increase in paco2 is noted during extended oxygenator use, briefly increasing the gas flow rate may improve the performance.Increase gas flow rate, to 20 l/min for 10 seconds.Do not repeat this flushing technique, even if oxygenator performance is not improved.(page10 warinig).".
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.2 to provide a correction to sections d1: brand name, d4: model number, d4: catalog number, and d4: udi.The udi was updated to match the correct format.Due to internal review, a correction was made to section d3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX®RX
Common Device Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomya city, MD 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
4103927218
MDR Report Key18363458
Report Number9681834-2023-00260
Device Sequence Number12765962
Product Code DTZ
UDI-Device Identifier04987350769572
UDI-Public(01)04987350769572(17)250731(10)220810
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K040210
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date07/31/2025
Device Model NumberCX*RX25RW
Device Catalogue NumberN/A
Device Lot Number220810
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/24/2023
Supplement Date Received by Manufacturer12/05/2023
08/08/2024
Initial Report FDA Received Date12/20/2023
Supplement Report FDA Received Date12/27/2023
08/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
Patient Weight92 KG
-
-